The Fourth Left Atrial Appendage Occlusion Study
The Fourth Left Atrial Appendage Occlusion Study (LAAOS-4)
Hamilton Health Sciences Corporation
4,000 participants
Nov 30, 2023
INTERVENTIONAL
Conditions
Summary
LAAOS-4 aims to determine if catheter-based endovascular left atrial appendage occlusion prevents ischemic stroke or systemic embolism in participants with atrial fibrillation, who remain at high risk of stroke, despite receiving ongoing treatment with oral anticoagulation.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Participants will undergo endovascular left atrial appendage occlusion with the WATCHMAN device
Locations(127)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05963698